Browse > Article
http://dx.doi.org/10.3961/jpmph.2013.46.4.165

Noncommunicable Diseases: Current Status of Major Modifiable Risk Factors in Korea  

Kim, Hyeon Chang (Department of Preventive Medicine, Yonsei University College of Medicine)
Oh, Sun Min (Medical Affairs, Novartis Korea Oncology)
Publication Information
Journal of Preventive Medicine and Public Health / v.46, no.4, 2013 , pp. 165-172 More about this Journal
Abstract
A noncommunicable disease (NCD) is a medical condition or disease that is by definition non-infectious and non-transmissible among people. Currently, NCDs are the leading causes of death and disease burden worldwide. The four main types of NCDs, including cardiovascular disease, cancer, chronic lung disease, and diabetes, result in more than 30 million deaths annually. To reduce the burden of NCDs on global health, current public health actions stress the importance of preventing, detecting, and correcting modifiable risk factors; controlling major modifiable risk factors has been shown to effectively reduce NCD mortality. The World Health Organization's World Health Report 2002 identified tobacco use, alcohol consumption, overweight, physical inactivity, high blood pressure, and high cholesterol as the most important risk factors for NCDs. Accordingly, the present report set out to review the prevalence and trends of these modifiable risk factors in the Korean population. Over the past few decades, we observed significant risk factor modifications of improved blood pressure control and decreased smoking rate. However, hypertension and cigarette smoking remained the most contributable factors of NCDs in the Korean population. Moreover, other major modifiable risk factors show no improvement or even worsened. The current status and trends in major modifiable risk factors reinforce the importance of prevention, detection, and treatment of risk factors in reducing the burden of NCDs on individuals and society.
Keywords
Noncommunicable disease; Risk factors; Prevalence; Trend; Korea;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Bagnardi V, Blangiardo M, La Vecchia C, Corrao G. A meta-analysis of alcohol drinking and cancer risk. Br J Cancer 2001;85(11):1700-1705.   DOI   ScienceOn
2 Corrao G, Bagnardi V, Zambon A, La Vecchia C. A meta-analysis of alcohol consumption and the risk of 15 diseases. Prev Med 2004;38(5):613-619.   DOI   ScienceOn
3 Babor TF, Higgins-Biddle JC, Saunders JB, Monteiro MG. The alcohol use disorders identification test: guidelines for use in primary care 2001 [cited 2013 Jul 1]. Available from:http://whqlibdoc.who.int/hq/2001/who_msd_msb_01.6a.pdf.
4 Yoon KH, Lee JH, Kim JW, Cho JH, Choi YH, Ko SH, et al. Epidemic obesity and type 2 diabetes in Asia. Lancet 2006;368(9548):1681-1688.   DOI   ScienceOn
5 Lim S, Shin H, Song JH, Kwak SH, Kang SM, Yoon JW, et al. Increasing prevalence of metabolic syndrome in Korea: the Korean National Health and Nutrition Examination Survey for 1998-2007. Diabetes Care 2011;34(6):1323-1328.   DOI   ScienceOn
6 Jung KW, Won YJ, Kong HJ, Oh CM, Seo HG, Lee JS. Cancer statistics in Korea: incidence, mortality, survival and prevalence in 2010. Cancer Res Treat 2013;45(1):1-14.   DOI   ScienceOn
7 Park JH, Lee KS, Choi KS. Burden of cancer in Korea during 2000-2020. Cancer Epidemiol 2013;37(4):353-359.   DOI   ScienceOn
8 Zammit C, Liddicoat H, Moonsie I, Makker H. Obesity and respiratory diseases. Int J Gen Med 2010;3:335-343.
9 World Health Organization. Global strategy on diet, physical activity and health [cited 2013 Jul 17]. Available from:http://www.who.int/dietphysicalactivity/factsheet_inactivity/en/index.html.
10 Sofi F, Capalbo A, Cesari F, Abbate R, Gensini GF. Physical activity during leisure time and primary prevention of coronary heart disease: an updated meta-analysis of cohort studies. Eur J Cardiovasc Prev Rehabil 2008;15(3):247-257.   DOI   ScienceOn
11 Lee CD, Folsom AR, Blair SN. Physical activity and stroke risk: a meta-analysis. Stroke 2003;34(10):2475-2481.   DOI   ScienceOn
12 Thune I, Furberg AS. Physical activity and cancer risk: dose-response and cancer, all sites and site-specific. Med Sci Sports Exerc 2001;33(6 Suppl):S530-S550.   DOI
13 Lee IM, Skerrett PJ. Physical activity and all-cause mortality: what is the dose-response relation? Med Sci Sports Exerc 2001;33(6 Suppl):S459- S471.   DOI   ScienceOn
14 Church T. Exercise in obesity, metabolic syndrome, and diabetes. Prog Cardiovasc Dis 2011;53(6):412-418.   DOI   ScienceOn
15 Oldridge NB. Economic burden of physical inactivity: healthcare costs associated with cardiovascular disease. Eur J Cardiovasc Prev Rehabil 2008;15(2):130-139.   DOI   ScienceOn
16 Lee DH, Kim YM, Jekal Y, Park S, Kim KC, Naruse M, et al. Low levels of physical activity are associated with increased metabolic syndrome risk factors in korean adults. Diabetes Metab J 2013;37(2):132-139.   DOI   ScienceOn
17 Jekal Y, Lee MK, Park S, Lee SH, Kim JY, Kang JU, et al. Association between obesity and physical fitness, and hemoglobin A1c level and metabolic syndrome in Korean adults. Korean Diabetes J 2010;34(3):182-190.   DOI   ScienceOn
18 Neaton JD, Wentworth DN, Cutler J, Stamler J, Kuller L. Risk factors for death from different types of stroke. Multiple Risk Factor Intervention Trial Research Group. Ann Epidemiol 1993;3(5):493-499.   DOI
19 Giroud M, Creisson E, Fayolle H, André N, Becker F, Martin D, et al. Risk factors for primary cerebral hemorrhage: a populationbased study--the Stroke Registry of Dijon. Neuroepidemiology 1995;14(1):20-26.   DOI
20 Kannel WB. Framingham study insights into hypertensive risk of cardiovascular disease. Hypertens Res 1995;18(3):181-196.   DOI
21 O'Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, Rao-Melacini P, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a casecontrol study. Lancet 2010;376(9735):112-123.   DOI   ScienceOn
22 Epstein M, Sowers JR. Diabetes mellitus and hypertension. Hypertension 1992;19(5):403-418.   DOI
23 Chow WH, Gridley G, Fraumeni JF Jr, Järvholm B. Obesity, hypertension, and the risk of kidney cancer in men. N Engl J Med 2000;343(18):1305-1311.   DOI   ScienceOn
24 Choi MY, Jee SH, Sull JW, Nam CM. The effect of hypertension on the risk for kidney cancer in Korean men. Kidney Int 2005;67(2):647-652.   DOI   ScienceOn
25 Kannel WB. Lipids, diabetes, and coronary heart disease: insights from the Framingham Study. Am Heart J 1985;110(5):1100-1107.   DOI   ScienceOn
26 Lee SY, Kim MT, Jee SH, Im JS. Does hypertension increase mortality risk from lung cancer? A prospective cohort study on smoking, hypertension and lung cancer risk among Korean men. J Hypertens 2002;20(4):617-622.   DOI   ScienceOn
27 Kim JS, Jones DW, Kim SJ, Hong YP. Hypertension in Korea: a national survey. Am J Prev Med 1994;10(4):200-204.
28 Kim IS, Lee YH, Suh I, Oh HC, Oh DK, Kim SJ, et al. Korean nationwide blood pressure study. Yonsei Med J 1982;23(1):15-25.   DOI
29 Kitahara CM, Berrington de González A, Freedman ND, Huxley R, Mok Y, Jee SH, et al. Total cholesterol and cancer risk in a large prospective study in Korea. J Clin Oncol 2011;29(12): 1592-1598.   DOI   ScienceOn
30 Freeman MR, Solomon KR. Cholesterol and prostate cancer. J Cell Biochem 2004;91(1):54-69.   DOI   ScienceOn
31 Ha M, Sung J, Song YM. Serum total cholesterol and the risk of breast cancer in postmenopausal Korean women. Cancer Causes Control 2009;20(7):1055-1060.   DOI   ScienceOn
32 Circulating cholesterol level and risk of death from cancer in men aged 40 to 69 years. Experience of an international collaborative group. JAMA 1982;248(21):2853-2859.   DOI   ScienceOn
33 Nomura AM, Stemmermann GN, Chyou PH. Prospective study of serum cholesterol levels and large-bowel cancer. J Natl Cancer Inst 1991;83(19):1403-1407.   DOI
34 Sorlie PD, Feinleib M. The serum cholesterol-cancer relationship: an analysis of time trends in the Framingham Study. J Natl Cancer Inst 1982;69(5):989-996.
35 Williams RR, Sorlie PD, Feinleib M, McNamara PM, Kannel WB, Dawber TR. Cancer incidence by levels of cholesterol. JAMA 1981;245(3):247-252.   DOI   ScienceOn
36 World Health Organization. Global Health Observatory (GHO): NCD mortality and morbidity [cited 2013 Jul 17]. Available from:http://www.who.int/gho/ncd/mortality_morbidity/en/.
37 Beaglehole R, Bonita R, Horton R, Adams C, Alleyne G, Asaria P, et al. Priority actions for the non-communicable disease crisis. Lancet 2011;377(9775):1438-1447.   DOI   ScienceOn
38 World Health Organization. Preventing chronic diseases: a vital investment [cited 2013 Jul 7]. Available from:http://www.who.int/chp/chronic_disease_report/en.
39 World Health Organization. Global Health Observatory (GHO): deaths from NCDs [cited 2013 Jul 1]. Available from:http://www.who.int/gho/ncd/mortality_morbidity/ncd_total/en/index.html.
40 World Health Organization. The world health report 2002: reducing risks, promoting healthy life [cited 2013 Jul 1]. Available from:http://www.who.int/whr/2002/en/index.html.
41 Jee SH, Samet JM, Ohrr H, Kim JH, Kim IS. Smoking and cancer risk in Korean men and women. Cancer Causes Control 2004;15(4):341-348.   DOI   ScienceOn
42 Jee SH, Suh I, Kim IS, Appel LJ. Smoking and atherosclerotic cardiovascular disease in men with low levels of serum cholesterol: the Korea Medical Insurance Corporation Study. JAMA 1999;282(22):2149-2155.   DOI   ScienceOn
43 Jee SH, Foong AW, Hur NW, Samet JM. Smoking and risk for diabetes incidence and mortality in Korean men and women. Diabetes Care 2010;33(12):2567-2572.   DOI   ScienceOn
44 Rennard SI, Vestbo J. COPD: the dangerous underestimate of 15%. Lancet 2006;367;(9518):1216-1219.   DOI   ScienceOn
45 Hur NW, Kim HC, Nam CM, Jee SH, Lee HC, Suh I. Smoking cessation and risk of type 2 diabetes mellitus: Korea Medical Insurance Corporation Study. Eur J Cardiovasc Prev Rehabil 2007;14(2):244-249.   DOI   ScienceOn
46 Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Measuring the global burden of disease and risk factors, 1990-2001. In: Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ, editors. Global burden of disease and risk factors. Washington,DC: World Bank; 2006, p. 1-13.
47 Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007;370(9589):765-773.   DOI   ScienceOn
48 Korea Centers for Disease Control and Prevention. Korea health statistics 2011: Korea National Health and Nutrition Examination Survey (KNHANES V-2). Seoul: Ministry of Health and Welfare; 2012, p. 22-27, 52-59 (Korean).
49 Jung-Choi KH, Khang YH, Cho HJ. Hidden female smokers in Asia: a comparison of self-reported with cotinine-verified smoking prevalence rates in representative national data from an Asian population. Tob Control 2012;21(6):536-542.   DOI   ScienceOn
50 Centers for Disease Control and Prevention (CDC). Alcohol-attributable deaths and years of potential life lost--United States, 2001. MMWR Morb Mortal Wkly Rep 2004;53(37):866-870.
51 O'Keefe JH, Bybee KA, Lavie CJ. Alcohol and cardiovascular health: the razor-sharp double-edged sword. J Am Coll Cardiol 2007;50(11):1009-1014.   DOI   ScienceOn
52 World Health Organization. Global status report on alcohol 2004 [cited 2013 Jul 1]. Available from: http://www.who.int/substance_abuse/publications/global_status_report_2004_overview.pdf.
53 Ariesen MJ, Claus SP, Rinkel GJ, Algra A. Risk factors for intracerebral hemorrhage in the general population: a systematic review. Stroke 2003;34(8):2060-2065.   DOI   ScienceOn
54 Sturgeon JD, Folsom AR, Longstreth WT Jr, Shahar E, Rosamond WD, Cushman M. Risk factors for intracerebral hemorrhage in a pooled prospective study. Stroke 2007;38(10):2718-2725.   DOI   ScienceOn